Galcanezumab

Monthly Subcutaneous Galcanezumab Effective for Migraine Prevention

Monthly Subcutaneous Galcanezumab Effective for Migraine Prevention

By

Monthly subcutaneous injections of galcanezumab at either 120 mg or 300 mg were effective for preventing migraines.

Episodic Migraines Possibly Prevented With Subcutaneous Galcanezumab

Episodic Migraines Possibly Prevented With Subcutaneous Galcanezumab

Researchers have found that monthly subcutaneous injection of galcanezumab significantly reduce migraine headache days.

Galcanezumab Monthly Injections Beneficial in Migraine Pain

Galcanezumab Monthly Injections Beneficial in Migraine Pain

By

Monthly galcanezumab injections at 120 mg or 240 mg offer clinical benefit in reducing migraine pain.

Sign Up for Free e-Newsletters